{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:42:24Z","timestamp":1768560144069,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute for Human Infections and Immunity at UTMB"},{"name":"Sealy Center for Vaccine Development at UTMB"},{"name":"Department of Homeland Security, Science and Technology Directorate, Office of University Programs"},{"name":"Institute for Translational Sciences UTMB-NIH","award":["1UL1RR029876-01"],"award-info":[{"award-number":["1UL1RR029876-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.03.076","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T18:40:37Z","timestamp":1335033637000},"page":"4095-4105","source":"Crossref","is-referenced-by-count":26,"title":["Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H\/HeN mice"],"prefix":"10.1016","volume":"30","author":[{"given":"Katherine","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Kolokoltsova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Poussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slobodan","family":"Paessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.03.076_bib0005","series-title":"Fields virology","first-page":"1023","article-title":"Alphaviruses","author":"Griffin","year":"2007"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.03.076_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0264-410X(96)00204-6","article-title":"Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB\/c, but not C3H\/HeN mice","volume":"15","author":"Hart","year":"1997","journal-title":"Vaccine"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.03.076_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Veterinary Pathology"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2012.03.076_bib0025","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2008.01.007","article-title":"C3H\/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection","volume":"78","author":"Julander","year":"2008","journal-title":"Antiviral Research"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2012.03.076_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.antiviral.2008.07.002","article-title":"Treatment of Venezuelan equine encephalitis virus infection with (\u2212)-carbodine","volume":"80","author":"Julander","year":"2008","journal-title":"Antiviral Research"},{"issue":"3","key":"10.1016\/j.vaccine.2012.03.076_bib0035","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"Brandstadter","year":"2011","journal-title":"Journal of Innate Immunity"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.03.076_bib0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/JVI.78.2.585-594.2004","article-title":"CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells","volume":"78","author":"Trifilo","year":"2004","journal-title":"Journal of Virology"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2012.03.076_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneuroim.2007.09.006","article-title":"The role of natural killer cells in curbing neuroinflammation","volume":"191","author":"Segal","year":"2007","journal-title":"Journal of Neuroimmunology"},{"issue":"August (9)","key":"10.1016\/j.vaccine.2012.03.076_bib0050","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1084\/jem.20092749","article-title":"Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology","volume":"207","author":"Hao","year":"2010","journal-title":"Journal of Experimental Medicine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2012.03.076_bib0055","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.4049\/jimmunol.178.9.5779","article-title":"NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria","volume":"178","author":"Hansen","year":"2007","journal-title":"Journal of Immunology"},{"issue":"January (7229)","key":"10.1016\/j.vaccine.2012.03.076_bib0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.03.076_bib0065","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/eji.200939435","article-title":"Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?","volume":"39","author":"Sun","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0070","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1016\/j.vaccine.2011.09.130","article-title":"Rapid, non-invasive imaging of alphaviral brain infection: Reducing animal numbers and morbidity to identify efficacy of potential vaccines and antivirals","volume":"50","author":"Patterson","year":"2011","journal-title":"Vaccine"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.03.076_bib0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy \u2013 analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.03.076_bib0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics (Oxford, England)"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","author":"Wu","year":"2004","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0090","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Statistical Applications in Genetics and Molecular Biology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.03.076_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"issue":"10","key":"10.1016\/j.vaccine.2012.03.076_bib0100","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biology"},{"issue":"3","key":"10.1016\/j.vaccine.2012.03.076_bib0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0110","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1471-2105-7-S4-S17","article-title":"Evaluation of clustering algorithms for gene expression data","author":"Datta","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.076_bib0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.WCB.0000071885.63724.20","article-title":"Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells","volume":"23","author":"Chen","year":"2003","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.03.076_bib0120","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1128\/IAI.70.12.6638-6645.2002","article-title":"Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB\/c and C57BL\/6 mice","volume":"70","author":"Liu","year":"2002","journal-title":"Infection and Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.03.076_bib0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1189\/jlb.0804465","article-title":"Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis","volume":"77","author":"Elhofy","year":"2005","journal-title":"Journal of Leukocyte Biology"},{"issue":"May (5813)","key":"10.1016\/j.vaccine.2012.03.076_bib0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/291334a0","article-title":"In vivo effect of anti-asialo GM1 antibody on natural killer activity","volume":"291","author":"Kasai","year":"1981","journal-title":"Nature"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.03.076_bib0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1967.16.762","article-title":"Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man","volume":"16","author":"Alevizatos","year":"1967","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2012.03.076_bib0140","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1128\/JVI.01041-09","article-title":"Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff","volume":"83","author":"Simmons","year":"2009","journal-title":"Journal of Virology"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2012.03.076_bib0145","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/JVI.75.8.3706-3718.2001","article-title":"Role of alpha\/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5\u2032 untranslated region","volume":"75","author":"White","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.vaccine.2012.03.076_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01317831","article-title":"Interferon induction and sensitivity as correlates to virulence of Venezuelan encephalitis viruses for hamsters","volume":"51","author":"Jahrling","year":"1976","journal-title":"Archives of Virology"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2012.03.076_bib0155","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.4049\/jimmunol.178.12.7540","article-title":"Type I IFN contributes to NK cell homeostasis, activation, and antitumor function","volume":"178","author":"Swann","year":"2007","journal-title":"Journal of Immunology"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2012.03.076_bib0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"issue":"June (30)","key":"10.1016\/j.vaccine.2012.03.076_bib0165","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.03.076_bib0170","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1128\/IAI.72.12.6790-6798.2004","article-title":"The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice","volume":"72","author":"Kamath","year":"2004","journal-title":"Infection and Immunity"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.03.076_bib0175","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ni1210-1080","article-title":"More things in heaven and earth: defining innate and adaptive immunity","volume":"11","author":"Biron","year":"2010","journal-title":"Nature Immunology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.03.076_bib0180","doi-asserted-by":"crossref","first-page":"e1000816","DOI":"10.1371\/journal.ppat.1000816","article-title":"Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation","volume":"6","author":"Biron","year":"2010","journal-title":"PLoS Pathogens"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.03.076_bib0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.it.2007.04.001","article-title":"Keeping NK cells in highly regulated antiviral warfare","volume":"28","author":"Lee","year":"2007","journal-title":"Trends in Immunology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.03.076_bib0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/eji.200535342","article-title":"NK cell-mediated immunopathology during an acute viral infection of the CNS","volume":"36","author":"Alsharifi","year":"2006","journal-title":"European Journal of Immunology"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2012.03.076_bib0195","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"Journal of Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12004689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T17:07:20Z","timestamp":1713892040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12004689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":39,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12004689"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}